用机器学习预测的输入和一个大In Vivo药理动力学数据集来预测动物药理动力学的高透量生理基础的药理动力学模型
Davide Bassani1, Andrea Andrews-Morger1, Jin Zhang1
1Pharmaceutical Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
Molecular pharmaceutics
|January 30, 2026
概括
高通量生理学基础的药理动力学 (HT-PBPK) 建模只使用化学结构准确预测药物的特性. 这加快了药物发现的速度,用可靠的in silico预测取代了广泛的体外测试.
科学领域:
- 药理动力学和药物新陈代谢
- 计算化学和化学信息学
- 药物发现和开发 药物发现和开发
背景情况:
- 准确的药理动力学 (PK) 预测对于有效的药物发现至关重要,但传统的方法,如生理基础药理动力学 (PBPK) 模型,由于产量低和数据要求有限.
- 高通量PBPK (HT-PBPK) 方法可以快速进行大规模模拟,而机器学习 (ML) 可以直接从化学结构预测PK,从而绕过了体外数据的需求.
研究的目的:
- 为了评估企业HT-PBPK应用程序 (SwiftPK) 在动物PK数据的大数据集中预测十个PK终点的性能.
- 评估以ML管道为早期药物发现生成的in silico预测取代体外数据的可行性.
主要方法:
- 使用HTPK模拟模块的SwiftPK应用程序应用于9000多个化合物.
- 一个ML管道被用来生成所有体外参数输入的in silico预测,取代实验数据.
- 对动物PK数据进行了性能评估,对肝脏代谢清除的化合物进行了具体分析,并对高可靠性ML预测进行了高可靠性ML预测.
主要成果:
- HT-PBPK方法表现出高度预测性能的表现,大多数PK终点预测的误差在三到四倍之内.
- 预测准确性提高了预测通过肝脏代谢清除的化合物 (扩展清除分类系统类别2) 和使用高可靠性ML输入时.
- 成功早期应用的关键因素包括对初级消除途径的准确预测和高预测质量.
结论:
- 该研究验证了HT-PBPK与in silico ML衍生输入的实用性,以加速早期药物发现.
- 这种方法对于领先的识别和缺乏实验数据的合作特别有价值.
- 采用HT-PBPK可以通过提高PK预测的效率和可靠性来加快新疗法的开发.
相关概念视频
Model Approaches for Pharmacokinetic Data: Physiological Models
274
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
274
Model Approaches for Pharmacokinetic Data: Compartment Models
557
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
557
Physiological Pharmacokinetic Models: Assumption with Protein Binding
256
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
256
Analysis of Population Pharmacokinetic Data
748
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
748
Pharmacokinetic Models: Overview
2.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
249
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
249


